Literature DB >> 25546803

Intravenous immunoglobulin as an intervention strategy of risk factor modification for prevention of severe infection in heart transplantation.

E Sarmiento1, M Arraya, M Jaramillo, P Diez, J Fernandez-Yañez, J Palomo, J Navarro, J Carbone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25546803      PMCID： PMC4285532          DOI： 10.1111/cei.12552

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN： 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  10 in total

1.  Chronic inflammatory demyelinating polyradiculoneuropathy: a prevalence study in south east England.

Authors:  M P Lunn; H Manji; P P Choudhary; R A Hughes; P K Thomas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-05       Impact factor: 10.154

2.  The impact of CytoGam on cardiac transplant recipients with moderate hypogammaglobulinemia: a randomized single-center study.

Authors:  Mohamad H Yamani; Robin Avery; Steven D Mawhorter; Ann McNeill; Daniel Cook; Norman B Ratliff; David Pelegrin; Phyllis Colosimo; Karen Kiefer; Kristin Ludrosky; Robert Hobbs; David Taylor; Tiffany Buda; Michael Yeager; James B Young; Nicholas Smedira; Randall C Starling
Journal:  J Heart Lung Transplant       Date:  2005-11       Impact factor: 10.247

3.  IgG monitoring to identify the risk for development of infection in heart transplant recipients.

Authors:  E Sarmiento; J J Rodriguez-Molina; J Fernandez-Yañez; J Palomo; R Urrea; P Muñoz; E Bouza; E Fernandez-Cruz; J Carbone
Journal:  Transpl Infect Dis       Date:  2006-03       Impact factor: 2.228

4.  Decreased levels of serum complement C3 and natural killer cells add to the predictive value of total immunoglobulin G for severe infection in heart transplant recipients.

Authors:  E Sarmiento; N del Pozo; A Gallego; J Fernández-Yañez; J Palomo; A Villa; M Ruiz; P Muñoz; C Rodríguez; J Rodríguez-Molina; J Navarro; K Kotsch; E Fernandez-Cruz; J Carbone
Journal:  Transpl Infect Dis       Date:  2012-10       Impact factor: 2.228

Review 5.  Immunological risk factors for infection after immunosuppressive and biologic therapies.

Authors:  Javier Carbone; Nadia del Pozo; Antonio Gallego; Elizabeth Sarmiento
Journal:  Expert Rev Anti Infect Ther       Date:  2011-04       Impact factor: 5.091

6.  Management of immune dysfunction after adult cardiac surgery.

Authors:  J Scott Rankin; Olusola Oguntolu; Robert S Binford; D Scott Trochtenberg; Lawrence H Muhlbaier; Charles W Stratton
Journal:  J Thorac Cardiovasc Surg       Date:  2011-07-02       Impact factor: 5.209

7.  Restoration of humoral immunity after intravenous immunoglobulin replacement therapy in heart recipients with post-transplant antibody deficiency and severe infections.

Authors:  J Carbone; E Sarmiento; N Del Pozo; J J Rodriguez-Molina; J Navarro; J Fernandez-Yañez; J Palomo; A Villa; P Muñoz; E Fernandez-Cruz
Journal:  Clin Transplant       Date:  2012 May-Jun       Impact factor: 2.863

8.  Hypogammaglobulinemia after heart transplantation: impact of pre-emptive use of immunoglobulin replacement (CytoGam) on infection and rejection outcomes.

Authors:  M H Yamani; R Avery; S Mawhorter; J B Young; A McNeill; D J Cook; N B Ratiff; P McCarthy; R C Starling
Journal:  Transpl Infect Dis       Date:  2001       Impact factor: 2.228

Review 9.  Polyclonal intravenous immunoglobulin: an important additional strategy in sepsis?

Authors:  R Di Rosa; M Pietrosanti; G Luzi; S Salemi; R D'Amelio
Journal:  Eur J Intern Med       Date:  2014-05-27       Impact factor: 4.487

10.  What is the impact of hypogammaglobulinemia on the rate of infections and survival in solid organ transplantation? A meta-analysis.

Authors:  D F Florescu; A C Kalil; F Qiu; C M Schmidt; U Sandkovsky
Journal:  Am J Transplant       Date:  2013-08-06       Impact factor: 8.086
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.